KVP Capital Advisors »

Evolus shares owned by KVP Capital Advisors

Quarter-by-quarter ownership of Evolus (EOLS) shares owned by KVP Capital Advisors from 13F filings

Historical chart of KVP Capital Advisors investment in Evolus

Tip: Access up to 7 years of quarterly data

All positions including Evolus held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evolus by KVP Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.0M 150k 6.94

More positions owned by KVP Capital Advisors

Praxis Precision Medicines I Com New (PRAX)
Aadi Bioscience (WHWK)
Erasca (ERAS)
Trevi Therapeutics (TRVI)
Sutro Biopharma Com Shs (STRO)
Tango Therapeutics (TNGX)
Mbx Biosciences (MBX)
Protagonist Therapeutics (PTGX)
Edgewise Therapeutics (EWTX)
Tandem Diabetes Care Com New (TNDM)
Disc Medicine (IRON)
Savara (SVRA)
Arrivent Biopharma (AVBP)
Insmed Com Par $.01 (INSM)
Achieve Life Sciences (ACHV)

View all positions for KVP Capital Advisors

Top funds holding Evolus

Nantahala Capital Management
BlackRock
Braidwell
Frazier Life Sciences Management
Perceptive Advisors
Vanguard Capital Management
Stonepine Capital Management
Millennium Management
Geode Capital Management
Point72 Asset Management
Gail Mannix
Armistice Capital
State Street Corporation
Rice Hall James & Associates
Goldman Sachs Group

View all funds holding Evolus